Zdrowie i gospodarka · 21/01/2022

FDA Revokes Emergency Use Authorizations for COVID-19 Diagnostic Devices

The US Food and Drug Administration (FDA) has revoked five Emergency Use Authorizations (EUAs) for COVID-19 diagnostic devices, including tests from Cellex Inc., BioMérieux SA, Siemens Healthcare Diagnostics Inc., and Cepheid, due to concerns over their accuracy and effectiveness.